Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineages

Y Yumi Aoyama H Hiromi Yamazaki K Koutarou Nishimura M Masaki Nomura (1Department of Cancer Pathology, Graduate School of Medicine, The University of Osaka, Suita, Japan) T Tsukasa Shigehiro (1Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan) T Takafumi Suzuki W Weijia Zang Y Yota Tatara H Hiromi Ito Y Yasutaka Hayashi (1Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan) Y Yui Koike M Miki Fukumoto (1Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan) A Atsushi Tanaka (Division of Research Animal Laboratory and Translational Medicine, Research and Development Center, Osaka Medical and Pharmaceutical University) Y Yifan Zhang W Wataru Saika C Chihiro Hasegawa S Shuya Kasai (7Department of Stress Response Science, Biomedical Research Center, Hirosaki University Graduate School of Medicine, Hirosaki, Japan) Y Yingyi Kong (12Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, Japan) Y Yohei Minakuchi (Advanced Genomics Center, National Institute of Genetics) K Ken Itoh M Masayuki Yamamoto S Shinya Toyokuni A Atsushi Toyoda T Tomokatsu Ikawa (1Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan) A Akifumi Takaori-Kondo D Daichi Inoue

Abstract

Abstract The maintenance of cellular redox balance is crucial for cell survival and homeostasis and is disrupted with aging. Selenoproteins, comprising essential antioxidant enzymes, raise intriguing questions about their involvement in hematopoietic aging and potential reversibility. Motivated by our observation of messenger RNA downregulation of key antioxidant selenoproteins in aged human hematopoietic stem cells (HSCs) and previous findings of increased lipid peroxidation in aged hematopoiesis, we used selenocysteine transfer RNA (tRNASec) gene (Trsp) knockout (KO) mouse model to simulate disrupted selenoprotein synthesis. This revealed insights into the protective roles of selenoproteins in preserving HSC stemness and B-lineage maturation, despite negligible effects on myeloid cells. Notably, Trsp KO exhibited B lymphocytopenia and reduced HSCs’ self-renewal capacity, recapitulating certain aspects of aged phenotypes, along with the upregulation of aging-related genes in both HSCs and pre-B cells. Although Trsp KO activated an antioxidant response transcription factor NRF2, we delineated a lineage-dependent phenotype driven by lipid peroxidation, which was exacerbated with aging yet ameliorated by ferroptosis inhibitors such as vitamin E. Interestingly, the myeloid genes were ectopically expressed in pre-B cells of Trsp KO mice, and KO pro-B/pre-B cells displayed differentiation potential toward functional CD11b+ fraction in the transplant model, suggesting that disrupted selenoprotein synthesis induces the potential of B-to-myeloid switch. Given the similarities between the KO model and aged wild-type mice, including ferroptosis vulnerability, impaired HSC self-renewal and B-lineage maturation, and characteristic lineage switch, our findings underscore the critical role of selenoprotein-mediated redox regulation in maintaining balanced hematopoiesis and suggest the preventive potential of selenoproteins against aging-related alterations.

Article Details

Journal Blood
Volume / Issue Vol. 145, Issue 11
Published March 13, 2025
Pages 1149-1163
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (26)

Y

Yumi Aoyama

H

Hiromi Yamazaki

K

Koutarou Nishimura

M

Masaki Nomura

1Department of Cancer Pathology, Graduate School of Medicine, The University of Osaka, Suita, Japan

T

Tsukasa Shigehiro

1Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan

T

Takafumi Suzuki

W

Weijia Zang

Y

Yota Tatara

H

Hiromi Ito

Y

Yasutaka Hayashi

1Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan

Y

Yui Koike

M

Miki Fukumoto

1Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan

A

Atsushi Tanaka

Division of Research Animal Laboratory and Translational Medicine, Research and Development Center, Osaka Medical and Pharmaceutical University

Y

Yifan Zhang

W

Wataru Saika

C

Chihiro Hasegawa

S

Shuya Kasai

7Department of Stress Response Science, Biomedical Research Center, Hirosaki University Graduate School of Medicine, Hirosaki, Japan

Y

Yingyi Kong

12Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, Japan

Y

Yohei Minakuchi

Advanced Genomics Center, National Institute of Genetics

K

Ken Itoh

M

Masayuki Yamamoto

S

Shinya Toyokuni

A

Atsushi Toyoda

T

Tomokatsu Ikawa

1Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan

A

Akifumi Takaori-Kondo

D

Daichi Inoue